Harrow Health, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HROW research report →
Companywww.harrowinc.com
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation.
- CEO
- Mark L. Baum
- IPO
- 2007
- Employees
- 382
- HQ
- Nashville, TN, US
Price Chart
Valuation
- Market Cap
- $1.15B
- P/E
- -76.80
- P/S
- 4.28
- P/B
- 40.03
- EV/EBITDA
- 33.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 74.11%
- Op Margin
- 10.47%
- Net Margin
- -5.57%
- ROE
- -33.65%
- ROIC
- 8.55%
Growth & Income
- Revenue
- $272.30M · 36.41%
- Net Income
- $-5,139,000 · 70.60%
- EPS
- $-0.14 · 71.43%
- Op Income
- $38.61M
- FCF YoY
- 170.60%
Performance & Tape
- 52W High
- $54.85
- 52W Low
- $25.21
- 50D MA
- $36.51
- 200D MA
- $41.34
- Beta
- 0.34
- Avg Volume
- 854.36K
Get TickerSpark's AI analysis on HROW
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Graves Adrienne L | buy | 1,000 |
| May 18, 26 | SILVERNAIL LAUREN P | buy | 1,000 |
| May 15, 26 | Shojaei Amir | other | 10,000 |
| May 14, 26 | BAUM MARK L | buy | 10,000 |
| May 14, 26 | BOLL ANDREW R. | buy | 3,500 |
| Mar 3, 26 | Opaleye Management Inc. | sell | 59,000 |
| Mar 4, 26 | Opaleye Management Inc. | sell | 134,000 |
| Mar 3, 26 | Opaleye Management Inc. | sell | 1,309 |
| Mar 4, 26 | Opaleye Management Inc. | sell | 4,263 |
| Feb 27, 26 | Opaleye Management Inc. | sell | 5,000 |
Our HROW Coverage
We haven't published any research on HROW yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HROW Report →